Abstract
LP-40: Non-clinical Safety profile of a new i.v. Formulation of Rifabutin (BV100) – an Opportunity for new Treatments
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
